APA (7th ed.) Citation

Basoglu, T., Ozkerim, U., Oksuz, S., Kinikoglu, O., Yildirim, S., Kokten, S., . . . Turan, N. (2025). Triple-Negative Apocrine Carcinoma: Largest Cohort Highlights Unique Biology and Survival Advantage. Journal of Clinical Medicine, 14(19), 7103. https://doi.org/10.3390/jcm14197103

Chicago Style (17th ed.) Citation

Basoglu, Tugba, et al. "Triple-Negative Apocrine Carcinoma: Largest Cohort Highlights Unique Biology and Survival Advantage." Journal of Clinical Medicine 14, no. 19 (2025): 7103. https://doi.org/10.3390/jcm14197103.

MLA (9th ed.) Citation

Basoglu, Tugba, et al. "Triple-Negative Apocrine Carcinoma: Largest Cohort Highlights Unique Biology and Survival Advantage." Journal of Clinical Medicine, vol. 14, no. 19, 2025, p. 7103, https://doi.org/10.3390/jcm14197103.